Crohn'
Conditions
Interventions
None listed
Sponsors
Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed or suspected with CD who scheduled to have CE for all small bowel observation, and if necessary, were known gastrointestinal tract patency within 2 weeks prior to CE by some method including patency capsule. 2) Patients who understand the contents after receiving a written explanation, and receive written consent for free participation. 3) In the case of a minor, a patient who has obtained consent from a representative (guardian).
Exclusion criteria
Exclusion criteria: 1) Patients with unknown digestive tract patency and patients with gastrointestinal obstruction or fistula. 2) Patients who can not receive CE (Patients with cardiac pacemaker insertion, or other electronic medical devices, or dysphagia or dysphagia symptoms). 3) Patients who are pregnant and may be pregnant. 4) In addition, patients who were judged to be unable to participate in research by responsible researcher or shared doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate and frequency of Crohn's disease lesions by capsule endoscopy (CE) | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlativity of existing Crohn's disease lesion activity evaluation methods (CDAI, CECDAI, Lewis Score), frequency of adverse events, capsule endoscopy acceptance evaluation, usage of patency capsules, and patency capsule related Adverse events | — |
Countries
Japan
Contacts
Public ContactToshiyuki Sakurai
The Jikei University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine
Outcome results
None listed